Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 2/3 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 2Dermatologic 2Lymphoid 1Head & Neck 1CNS 1

Conditions

Breast Neoplasms 5Sleep Disorders, Circadian Rhythm 1Radiodermatitis 1Pain 1Depression 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Melatonin × Breast × Clear all
NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed
48 enrolled
Breast

Breast Neoplasms, Radiodermatitis

NCT02506777 2019-09-04

MBC1

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Unknown
96 enrolled
Breast

Breast Neoplasms

NCT02506790 2019-09-04

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Unknown
96 enrolled
Breast

Breast Neoplasms

NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Hospital de Clinicas de Porto Alegre

Phase 2 Completed
36 enrolled
Breast

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

NCT01965522 2017-06-16

MELO-D

Juravinski Cancer Center

Phase 2 Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡